These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787 [TBL] [Abstract][Full Text] [Related]
3. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II. Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468 [TBL] [Abstract][Full Text] [Related]
4. Menstrual cycle characteristics and steroid hormone, prolactin, and growth factor levels in premenopausal women. Farland LV; Mu F; Eliassen AH; Hankinson SE; Tworoger SS; Barbieri RL; Dowsett M; Pollak MN; Missmer SA Cancer Causes Control; 2017 Dec; 28(12):1441-1452. PubMed ID: 29086892 [TBL] [Abstract][Full Text] [Related]
5. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). Kaaks R; Berrino F; Key T; Rinaldi S; Dossus L; Biessy C; Secreto G; Amiano P; Bingham S; Boeing H; Bueno de Mesquita HB; Chang-Claude J; Clavel-Chapelon F; Fournier A; van Gils CH; Gonzalez CA; Gurrea AB; Critselis E; Khaw KT; Krogh V; Lahmann PH; Nagel G; Olsen A; Onland-Moret NC; Overvad K; Palli D; Panico S; Peeters P; Quirós JR; Roddam A; Thiebaut A; Tjønneland A; Chirlaque MD; Trichopoulou A; Trichopoulos D; Tumino R; Vineis P; Norat T; Ferrari P; Slimani N; Riboli E J Natl Cancer Inst; 2005 May; 97(10):755-65. PubMed ID: 15900045 [TBL] [Abstract][Full Text] [Related]
6. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women. Tamimi RM; Byrne C; Colditz GA; Hankinson SE J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278 [TBL] [Abstract][Full Text] [Related]
7. Serum levels of sex hormones and breast cancer risk in premenopausal women: a case-control study (USA). Sturgeon SR; Potischman N; Malone KE; Dorgan JF; Daling J; Schairer C; Brinton LA Cancer Causes Control; 2004 Feb; 15(1):45-53. PubMed ID: 14970734 [TBL] [Abstract][Full Text] [Related]
8. Effect of menstrual cycle phase on background parenchymal uptake at molecular breast imaging. Hruska CB; Conners AL; Vachon CM; O'Connor MK; Shuster LT; Bartley AC; Rhodes DJ Acad Radiol; 2015 Sep; 22(9):1147-56. PubMed ID: 26112057 [TBL] [Abstract][Full Text] [Related]
9. Associations of Serum Levels of Sex Hormones in Follicular and Luteal Phases of the Menstrual Cycle with Breast Tissue Characteristics in Young Women. Linton L; Taylor M; Dunn S; Martin L; Chavez S; Stanitz G; Huszti E; Minkin S; Boyd N PLoS One; 2016; 11(10):e0163865. PubMed ID: 27716810 [TBL] [Abstract][Full Text] [Related]
10. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Tworoger SS; Eliassen AH; Missmer SA; Baer H; Rich-Edwards J; Michels KB; Barbieri RL; Dowsett M; Hankinson SE Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2494-501. PubMed ID: 17164375 [TBL] [Abstract][Full Text] [Related]
11. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women. Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735 [TBL] [Abstract][Full Text] [Related]
12. Alcohol intake and endogenous sex hormones in women: Meta-analysis of cohort studies and Mendelian randomization. Tin Tin S; Smith-Byrne K; Ferrari P; Rinaldi S; McCullough ML; Teras LR; Manjer J; Giles G; Le Marchand L; Haiman CA; Wilkens LR; Chen Y; Hankinson S; Tworoger S; Eliassen AH; Willett WC; Ziegler RG; Fuhrman BJ; Sieri S; Agnoli C; Cauley J; Menon U; Fourkala EO; Rohan TE; Kaaks R; Reeves GK; Key TJ Cancer; 2024 Oct; 130(19):3375-3386. PubMed ID: 38824654 [TBL] [Abstract][Full Text] [Related]
13. Plasma sex steroid hormones and breast cancer risk in Chinese women. Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036 [TBL] [Abstract][Full Text] [Related]
14. Endogenous sex hormone levels and mammographic density among postmenopausal women. Tamimi RM; Hankinson SE; Colditz GA; Byrne C Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2641-7. PubMed ID: 16284390 [TBL] [Abstract][Full Text] [Related]
15. Alcohol consumption in relation to plasma sex hormones, prolactin, and sex hormone-binding globulin in premenopausal women. Hirko KA; Spiegelman D; Willett WC; Hankinson SE; Eliassen AH Cancer Epidemiol Biomarkers Prev; 2014 Dec; 23(12):2943-53. PubMed ID: 25281368 [TBL] [Abstract][Full Text] [Related]
16. Associations between endogenous sex hormone levels and mammographic and bone densities in premenopausal women. Yong M; Atkinson C; Newton KM; Aiello Bowles EJ; Stanczyk FZ; Westerlind KC; Holt VL; Schwartz SM; Leisenring WM; Lampe JW Cancer Causes Control; 2009 Sep; 20(7):1039-53. PubMed ID: 19280356 [TBL] [Abstract][Full Text] [Related]
17. Hormonal determinants of mammographic density and density change. Gabrielson M; Azam S; Hardell E; Holm M; Ubhayasekera KA; Eriksson M; Bäcklund M; Bergquist J; Czene K; Hall P Breast Cancer Res; 2020 Aug; 22(1):95. PubMed ID: 32847607 [TBL] [Abstract][Full Text] [Related]
18. Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Noh JJ; Maskarinec G; Pagano I; Cheung LW; Stanczyk FZ Breast; 2006 Feb; 15(1):20-8. PubMed ID: 16000251 [TBL] [Abstract][Full Text] [Related]
19. Physical activity and inactivity in relation to sex hormone, prolactin, and insulin-like growth factor concentrations in premenopausal women - exercise and premenopausal hormones. Tworoger SS; Missmer SA; Eliassen AH; Barbieri RL; Dowsett M; Hankinson SE Cancer Causes Control; 2007 Sep; 18(7):743-52. PubMed ID: 17549594 [TBL] [Abstract][Full Text] [Related]
20. Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide. Johansson H; Bonanni B; Gandini S; Guerrieri-Gonzaga A; Cazzaniga M; Serrano D; Macis D; Puccio A; Sandri MT; Gulisano M; Formelli F; Decensi A Breast Cancer Res Treat; 2013 Dec; 142(3):569-78. PubMed ID: 24241787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]